Structure of immune molecule that counteracts HIV strains determined
June 2nd, 2010 - 4:13 pm ICT by ANIWashington, June 2 (ANI): A team led by Scripps Research Institute scientists has determined the structure of an immune system antibody molecule that effectively acts against most strains of human immunodeficiency virus (HIV), the virus that causes AIDS.
Published in an advance, online issue of the journal Proceedings of the National Academy of Sciences (PNAS) during the week of June 1, 2010, the study illuminates an unusual human antibody called PG16.
“This study advances the overall goal of how to design an HIV vaccine,” said Scripps Research Professor Ian Wilson, who led the team with Dennis Burton, Scripps Research professor and scientific director of the International AIDS Vaccine Initiative (IAVI) Neutralizing Antibody Center at Scripps Research. “This antibody is highly effective in neutralizing HIV-1 and has evolved novel features to combat the virus.”
According to the World Health Organization’s latest statistics, around 33 million people are living with HIV worldwide. During 2008 alone, more than 2 million men, women, and children succumbed to the disease and an estimated 2.7 million were infected with HIV.
One of the most compelling medical challenges today is to develop a vaccine that will provide complete protection to someone who is later exposed to this virus.
HIV causes AIDS by binding to, entering, and ultimately leading to the death of T helper cells, which are immune cells that are necessary to fight off infections by common bacteria and other pathogens. As HIV depletes the body of T helper cells, common pathogens can become potentially lethal.
An effective HIV vaccine would induce antibodies (specialized immune system molecules) against the virus prior to exposure to the virus. Also called immunoglobulins, these antibodies would circulate through the blood, and track down and kill the virus. (ANI)
- THSTI,IAVI announce new HIV vaccine design program in India - Mar 04, 2011
- Vaccine-delivering nanoparticles may help fight HIV, malaria - Feb 23, 2011
- Breast milk antibodies help neutralize HIV - May 23, 2012
- 'Pep talk' can revive exhausted immune cells: Study - Dec 14, 2011
- New findings bring scientists closer to an effective HIV vaccine - Jan 15, 2011
- Promising target for AIDS vaccine identified - Apr 01, 2011
- 2 new antibodies may pave way for powerful AIDS vaccine - Sep 04, 2009
- Tweaking antibody could lead to vaccine against HIV - May 08, 2011
- Novel discoveries offer new ways to design HIV vaccine - Sep 30, 2010
- New approach to fight HIV could spur vaccine development - Sep 28, 2010
- Russia tests HIV vaccine - Feb 06, 2012
- Unearthing Of Antibodies Could Assist The Discovery Of An AIDS Vaccine - Jul 09, 2010
- Scientists locate malaria parasites' Achilles heal - Apr 22, 2012
- Do immune cells control their own destiny? - Jan 09, 2012
- HIV vaccine comes closer to reality - Sep 22, 2009
Tags: antibody molecule, dennis burton, helper cells, hiv causes aids, hiv strains, hiv vaccine, human antibody, human immunodeficiency virus, immune cells, immune molecule, immunodeficiency virus hiv, institute scientists, international aids vaccine, international aids vaccine initiative, journal proceedings, medical challenges, national academy of sciences, proceedings of the national academy of sciences, scripps research institute, world health organization